Primer: JBM (Healthcare) (2161 HK) - Aug 2026
JBM Healthcare is a prominent player in Hong Kong's Proprietary Chinese Medicine (PCM) market, leveraging a portfolio of well-established,...
JBM (Healthcare) (2161 HK): Synthetic Expert Call Transcript (21 Jul 2026)
The Proposed Spin-Off of JPJ (TCM) Limited Lacks Commercial Substance: Creating a three-tier listed structure (Jacobson Pharma to JBM Healthcare...
Limited Upside To JBM (2161 HK)'s Spin-Off
JBM is hedging on JPJ's "heritage brand + clinic synergy" offsetting JPJ's illiquidity. The key beneficiary is likely JBM's chairman & main...
Last Week In Event SPACE: Mitsui Matsushima, Prosus/Tencent/Naspers, Legend/Lenovo
It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...
No more insights